Ventyx Biosciences, Inc. Balance Sheet
VTYX / Health Care|5 years of annual SEC 10-K data (FY2020-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Ventyx Biosciences, Inc. had $277M in total assets and $254M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | $27.3M | $51.6M | $64.8M | $70.8M | $244.0K |
| Current Assets | $229.6M | $264.3M | $330.7M | $263.0M | $245.0K |
| PP&E (Net) | $614.0K | $762.0K | $407.0K | $254.0K | $0 |
| Total Assets | $276.6M | $277.7M | $371.4M | $291.5M | $245.0K |
| Current Liabilities | $12.8M | $22.3M | $16.4M | $12.3M | $1.4M |
| Shareholders' Equity | $254.0M | $243.9M | $353.9M | $279.2M | -$30.7M |